Suppr超能文献

早发性溶酶体酸性脂肪酶缺乏症表现为继发性噬血细胞性淋巴组织细胞增生症:两例接受司贝前列素治疗的婴儿。

Early onset lysosomal acid lipase deficiency presenting as secondary hemophagocytic lymphohistiocytosis: Two infants treated with sebelipase alfa.

机构信息

Gastroenterology unit, Pediatrics Division, Child and Adolescent Department, Centro Materno-Infantil do Norte, Centro Hospitalar Universitário do Porto, Largo da Maternidade, 4050-651 Porto, Portugal; Instituto de Ciências Biomédicas Abel Salazar, Porto, Portugal.

Department of Gastroenterology, Hepatology, Nutritional Disorders and Paediatrics, Children's Memorial Health Institute, Warsaw, Poland.

出版信息

Clin Res Hepatol Gastroenterol. 2018 Oct;42(5):e77-e82. doi: 10.1016/j.clinre.2018.03.012. Epub 2018 Apr 26.

Abstract

Two unrelated infants were diagnosed with and initially treated for hemophagocytic lymphohistiocytosis (HLH), but progressed to cholestasis and liver failure. Early onset lysosomal acid lipase deficiency (EO-LAL-D) was suspected due to lymphocytes with cytoplasmic vacuolation and/or adrenal calcifications and confirmed by enzymatic and genetic analysis. Enzyme replacement therapy with sebelipase alfa was implemented, but both children died, despite initial improvement. Since this inborn error of metabolism progresses rapidly in infants, early diagnosis is crucial, and appropriate treatment should be started as soon as possible. The authors suggest that the diagnosis of EO-LAL-D should be considered in infants with symptoms of HLH.

摘要

两名无关联的婴儿被诊断并初步治疗噬血细胞性淋巴组织细胞增生症(HLH),但随后出现胆汁淤积和肝功能衰竭。由于淋巴细胞胞质有空泡和/或肾上腺钙化,疑似早发性溶酶体酸性脂肪酶缺乏症(EO-LAL-D),并通过酶和基因分析得到证实。使用 sebelipase alfa 进行酶替代治疗,但两名儿童均死亡,尽管最初有所改善。由于这种先天性代谢缺陷在婴儿中进展迅速,因此早期诊断至关重要,一旦确诊应尽快开始适当治疗。作者建议,对于有 HLH 症状的婴儿,应考虑 EO-LAL-D 的诊断。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验